GSK Consumer soars 20 pct on parent's open offer plan
MUMBAI (Reuters) - Shares in GlaxoSmithKline Consumer Healthcare (GLSM.NS), the Indian arm of GlaxoSmithKline (GSK.L), surged 20 percent to their maximum daily limit on Monday, following news that its UK-based parent group plans to raise its stake in the unit via an open offer.
GlaxoSmithKline Plc (GSK.L), along with its units, will buy up to 13.39 million shares, or an additional 31.84 percent in GlaxoSmithKline Consumer Healthcare, at 3,900 rupees per share, said HSBC Securities, the manager to the offer, in a statement.
Valued at $2.3 billion, shares in GSK Consumer Healthcare were locked at 3,659.20 rupees, up 20 percent to their maximum daily trading limit, while the Sensex was up 0.42 percent by 9:36 a.m. (Reporting by Kaustubh Kulkarni and Manoj Dharra; Editing by Jijo Jacob)
- Tweet this
- Share this
- Digg this
- UPDATE 4-JetBlue flight makes emergency landing at California airport, 4 hurt
- Scots independence polls close, UK's future in the balance
- UPDATE 1-Microsoft lays off 2,100, axes Silicon Valley research
- UPDATE 2-Two small Russian banks taken off Canada sanctions list
- UPDATE 2-Russia approves tough budget as sanctions restrict growth
China is not a warlike nation, President Xi Jinping said on Thursday, during a rare trip to neighbour India that was dominated by a standoff on a barren Himalayan plateau between soldiers from the world's two most populous nations. Full Article | Slideshow
Obama to nominate Indian-American Richard Verma as India ambassador - congressional source. Full Article